Novo Nordisk has launched legal action accusing Eli Lilly of creating “misleading” ads, a claim its rival denies.
Major stock exchanges worldwide responded positively to trade agreement developments
Major stock exchanges worldwide responded positively to trade agreement developments
Novo Nordisk has launched legal action accusing Eli Lilly of creating “misleading” ads, a claim its rival denies.